Caris Life Sciences, Inc. (CAI)
14.55
-0.70
(-4.59%)
USD |
NASDAQ |
May 15, 16:00
14.75
+0.20
(+1.37%)
After-Hours: 20:00
Caris Life Sciences Total Liabilities (Quarterly) : 568.90M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Neurocrine Biosciences, Inc. | 1.499B |
| Nuvalent, Inc. | 156.78M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
| Glaukos Corp. | 222.40M |
| CytomX Therapeutics, Inc. | 39.41M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.162B |
| Shareholders Equity (Quarterly) | 593.49M |
| Debt to Equity Ratio | 0.7261 |
| Current Ratio | 7.048 |
| Net Debt Paydown Yield | -0.03% |